These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2404283)

  • 1. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
    Kasid A; Morecki S; Aebersold P; Cornetta K; Culver K; Freeman S; Director E; Lotze MT; Blaese RM; Anderson WF
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):473-7. PubMed ID: 2404283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
    Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
    Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.
    Merrouche Y; Negrier S; Bain C; Combaret V; Mercatello A; Coronel B; Moskovtchenko JF; Tolstoshev P; Moen R; Philip T
    J Clin Oncol; 1995 Feb; 13(2):410-8. PubMed ID: 7844602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells.
    Morecki S; Karson E; Cornetta K; Kasid A; Aebersold P; Blaese RM; Anderson WF; Rosenberg SA
    Cancer Immunol Immunother; 1991; 32(6):342-52. PubMed ID: 2007247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes as cellular vehicles for gene therapy in mouse and man.
    Culver K; Cornetta K; Morgan R; Morecki S; Aebersold P; Kasid A; Lotze M; Rosenberg SA; Anderson WF; Blaese RM
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3155-9. PubMed ID: 2014235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene.
    Yamaue H; Kashmiri SV; De Filippi R; Nieroda C; Yannelli JR; Tsang KY; Schlom J
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):262-74. PubMed ID: 7881635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent.
    Liu K; Rosenberg SA
    J Immunother; 2003; 26(3):190-201. PubMed ID: 12806273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
    Rosenberg SA; Aebersold P; Cornetta K; Kasid A; Morgan RA; Moen R; Karson EM; Lotze MT; Yang JC; Topalian SL
    N Engl J Med; 1990 Aug; 323(9):570-8. PubMed ID: 2381442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
    Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
    Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.
    Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
    Cancer Immunol Immunother; 1995 Feb; 40(2):95-102. PubMed ID: 7882388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
    Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W
    Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of gene therapy for the treatment of cancer.
    Rosenberg SA; Anderson WF; Blaese M; Hwu P; Yannelli JR; Yang JC; Topalian SL; Schwartzentruber DJ; Weber JS; Ettinghausen SE
    Ann Surg; 1993 Oct; 218(4):455-63; discussion 463-4. PubMed ID: 8215637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
    J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
    Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
    Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
    Reeves ME; Royal RE; Lam JS; Rosenberg SA; Hwu P
    Cancer Res; 1996 Dec; 56(24):5672-7. PubMed ID: 8971174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study.
    Aebersold P; Kasid A; Rosenberg SA
    Hum Gene Ther; 1990; 1(4):373-84. PubMed ID: 1964094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.
    Hughes MS; Yu YY; Dudley ME; Zheng Z; Robbins PF; Li Y; Wunderlich J; Hawley RG; Moayeri M; Rosenberg SA; Morgan RA
    Hum Gene Ther; 2005 Apr; 16(4):457-72. PubMed ID: 15871677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
    Trentin L; Zambello R; Bulian P; Cerutti A; Milani A; Pirone E; Nitti D; Agostini C; Semenzato G
    Br J Cancer; 1994 Jun; 69(6):1046-51. PubMed ID: 8198969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.